~~<i id='A687243EDD'><strike id='A687243EDD'><tt id='A687243EDD'><pre id='A687243EDD'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

entertainment

Wikipedia

author：comprehensive 2025-09-05 13:43:30 - browse：74777

Alkermes shareholders voted Thursday to re-elect all of the drugmaker’s current directors, ending an acrimonious proxy fight with hedge fund Sarissa Capital Management, which had sought to seat three directors on the board.

At the company’s annual meeting, shareholders voted in favor of Alkermes’ proposal to retain all seven of the director nominees to the 11-person board.

The outcome is a setback for Sarissa, which owns 8.5% of Alkermes and is run by activist investor Alex Denner. Sarissa has accused Alkermes executives of mismanaging the business and destroying shareholder value.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Supreme Court strikes down use of affirmative action
Next article： Do digital therapeutics have a future in medicine?

entertainment

explore

hotspot

knowledge

entertainment

knowledge

AdobeSouthKoreaistheonlycountrytoofficiallyrecognizedigitaltherapeuticsasacategory.Nevertheless,thec

WSS

California’s proposed $25 per hour health care minimum wage

Study: Pain burden is higher in Black NFL players than white ones

Commercial surrogacy can be ethical, despite pope’s claims

Do digital therapeutics have a future in medicine?

What we need to know about Arena Bioworks

Readout Newsletter: Vertex, Biogen's Aduhelm, and Bristol updates

entertainment

Wikipedia

entertainment

State Dept. review finds Biden bears some blame for Afghanistan failures

Bulgari apologizes to China for listing Taiwan as a country after online backlash

After affirmative action ruling, medical educators look to 'holistic review'

Apple Vision Pro: A first look at health apps on the new VR headset

United colonoscopy coverage change 'may cost lives,' doctors say

New Ultima Genomics DNA sequencer can read genome for $100

23andMe had bad news about my health. I wish a person had delivered it

What we need to know about Arena Bioworks

Bright Health sells Medicare Advantage business to Molina

HCA discloses massive data breach affecting 11 million patients

explore

Iowa House, Senate pass 6

Threats against the LGBTQIA+ community intensifying: Department of Homeland Security

The real point of Kenneth Smith’s execution by nitrogen gas

How the political right came to back psychedelics to treat trauma

Living with Fabry disease, a condition that causes chronic pain

Quicker fix for pulse oximeters urged during FDA public meeting

hotspot

knowledge

entertainment

knowledge